Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Z PORTFOLIO -- Ignore unavailable to you. Want to Upgrade?

To: Larry S. who wrote (3865)	1/5/2000 1:21:00 PM
From: Volsi Mimir	Read Replies (1) \| Respond to of 11568

I'll sponsor a stock TTP - Titan Pharmecutical Bio's sector hot, company is in a good position for great growth and stock price. 1000Sh@ 15 3/4(it was low as 15 and now 13:17 15 3/4) held for a year for double IMHO, any good news should get to 21-22 in a quarter or two Recently redeemed their warrants, got coverage, pipes good, titanpharm.com stratagies titanpharm.com From Yahoo: product candidates include Zomaril(TM) for the treatment of schizophrenia and Spheramine(TM), a cell-based treatment for Parkinson's disease. Cancer product candidates include CeaVac(TM), TriAb(TM) and TriGem(TM), all of which utilize anti-idiotypic antibody technology. The Company is also currently developing Pivanex(TM) for differentiation therapy and the gene therapy product RB94. disclosure: I own it from 9+ and bought recently more 17 5/8 so I think this will go above my last buy